Philadelphia, PA · Founded 2022 · Privately Held (backing)
Developer of a cell-based therapeutic platform intended to overcome bottlenecks in gene therapy manufacturing. BlueWhale Bio is based in Philadelphia, PA and was founded in 2022. It was valued at $52 million at its early-stage round in Oct 2025, the last priced event on record. It has raised $23 million across 1 recorded round; the latest was a $5 million early-stage round in Oct 2025.
PMV mark · valuation
$52.0M
Oct 2026
Priced at
its early-stage round
Oct 2025
Total raised
$23.0M
Last round
Early Stage VC
Oct 2025
Cap table — not yet on record
BlueWhale Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of BlueWhale Bio with a free account
·Watch BlueWhale Bio: the Monday email on marks, rounds and moves
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across BlueWhale Bio's 1 recorded funding rounds.
